Soal McQ TB dan Kanker Paru

Soal McQ TB dan Kanker Paru

Professional Development

52 Qs

quiz-placeholder

Similar activities

CUESTIONARIO EVALUATIVO ENCUENTRO NAF

CUESTIONARIO EVALUATIVO ENCUENTRO NAF

Professional Development

51 Qs

Bull Quiz-01 ( August)

Bull Quiz-01 ( August)

Professional Development

50 Qs

Skill Pertanian bag 11

Skill Pertanian bag 11

KG - Professional Development

50 Qs

CPD222Final

CPD222Final

Professional Development

50 Qs

Soal McQ TB dan Kanker Paru

Soal McQ TB dan Kanker Paru

Assessment

Quiz

Education

Professional Development

Easy

Created by

Andis Wulandari

Used 1+ times

FREE Resource

52 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 45-year-old man, coughing up blood, shortness of breath, night sweats. BTA (+), GeneXpert: Rif-sensitive. Initial therapy?

2HRZE / 4HR

2RHZE / 6HE

6HRZE

2RHZ / 7HR

2HRZE / 4HRE

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 60-year-old woman, spinal TB, complains of pain and mild paralysis. Therapy?

Standard OAT + corticosteroids

OAT + surgery if there is neurological deficit

Surgery only

OAT only

Just observation

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 33-year-old man with HIV+, BTA (+), on OAT day 10, suddenly has severe shortness of breath and high fever. Diagnosis?

TB reactivation

IRIS

Bacterial pneumonia

TB RO

Superinfection

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 5-year-old child with TB, weight <10 kg, vomits after taking OAT. Best preparation choice?

Half adult tablet

FDC syrup OAT

FDC child tablet

Mix powder

Single OAT

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A patient with TB RO, Hb 6 g/dL, platelets 80,000, leukocytes decreased. Which drug side effect is likely?

Levofloxacin

Clofazimine

Linezolid

Ethionamide

Bedaquiline

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 29-year-old man, coughing for 2 months, night sweats. IGRA and TST tests positive. Diagnosis?

Latent TB

Active TB

TB RO

Not TB

Pneumonia

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

A 40-year-old woman, lung cancer, EGFR (+), planned for targeted therapy. Choice of drug?

Gefitinib

Osimertinib

Erlotinib

Dacomitinib

Alectinib

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?